Pharmacovigilance

Any adverse events relating to Baxter products should be reported to Baxter’s Pharmacovigilance team using the following contact details:

Phone: 01635 206360

Email: vigilanceuk@baxter.com

Ensuring patient safety is extremely important to us and we take the safety of all our medicines and devices very seriously.
Adverse Events may also be reported to the MHRA; reporting forms and information can be found at www.mhra.gov.uk/yellowcard

Important safety links

Information on the correct use of Baxter fibrin sealants with spray application: www.baxterspraysafety.com 

Information on the use of glucose monitors in patients using Extraneal: www.glucosesafety.com/cont-eu.html 

Any personal data sent to us will be protected, anonymised, entered into our safety database and reported to global government medicines agencies in line with the Baxter’s Privacy Policy and legal requirements.